The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...